Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized tacrolimus dosing and once-daily tacrolimus pharmacokinetics in pediatric kidney transplant recipients
NL-OMON51392Phase 4Recruiting
- Sponsor
- Erasmus MC
- Start
- May 2024
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tacrolimus, sponsored by Erasmus MC. Started May 2024; status: recruiting.
02
Drugs
tacrolimus
Beyond the preview
Go deeper on NL-OMON51392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51392.